114 results
Page 4 of 6
6-K
EX-1
irvlk4c
26 Oct 20
Current report (foreign)
9:00am
6-K
EX-1
wd813x5gvr56gp 7fc7
13 Oct 20
Current report (foreign)
10:30am
6-K
EX-1
o69jnsotw6 mr5ujr
22 Sep 20
Current report (foreign)
10:08am
6-K
EX-99.1
en3fv
8 Sep 20
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
8:30am
6-K
EX-2
uxg35
13 Aug 20
Current report (foreign)
7:03am
6-K
EX-1
uk9k1 7n4hcc
27 Jul 20
Current report (foreign)
7:00am
6-K
EX-2
j61k3f
27 May 20
Current report (foreign)
7:00am
6-K
EX-99.1
ia337teeppcqo19g
28 Apr 20
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
7:00am
6-K
EX-99.1
hvndd s9i8pby0
13 Mar 20
RedHill recently launched Talicia® in the U.S., calling on gastroenterologists, primary care physicians and other healthcare providers
7:00am
6-K
EX-99.1
8qsnce2dfei iq0itu
9 Mar 20
RedHill Biopharma Announces U.S. Commercial Launch of Talicia® for H. pylori Infection
7:04am
6-K
EX-99.1
qdv3il76uc
27 Jan 20
RedHill Biopharma Launches H. pylori Disease State Awareness Field Campaign Ahead of Talicia® Launch
7:00am
6-K
EX-99.1
58pfs5
4 Nov 19
RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults
6:05am
6-K
EX-99.1
a9gq2y pr4v762bb
16 Oct 19
Current report (foreign)
8:00am
424B5
8ood9k1p zg
23 Jul 19
Prospectus supplement for primary offering
8:31am
6-K
EX-2
8i6u23hfsyfv
23 Jul 19
Current report (foreign)
7:27am
6-K
EX-99.1
wm32suj 5p
3 Jul 19
Current report (foreign)
7:00am
6-K
EX-1
f6hgf
7 May 19
Current report (foreign)
7:01am
6-K
EX-2
0qm07as gy
7 May 19
Current report (foreign)
7:01am